Susceptibility Weighted Imaging at Ultrahigh Magnetic Fields

Susceptibility Weighted Imaging in MRI: Basic Concepts and Clinical Applications

Volumn , Issue , 2011, Pages 329-349

  Deistung, Andreas ^a   Barnes, Samuel ^b   Ge, Yulin ^c   Reichenbach, Jürgen R ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b LOMA LINDA UNIVERSITY   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Image contrast, and ultrahigh field strengths powerful noninvasive approach, assessing normal and abnormal neuronal anatomy with high spatial resolution; Susceptibility weighted imaging at ultrahigh magnetic fields ultrahigh field MRI at 7 T 9.4 T or higher in human sized whole body systems, forefront of research; Ultrahigh field MRI, for structural, physiological and molecular imaging applications SWI with its unique contrast properties

Indexed keywords

EID: 84886218002     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470905203.ch20     Document Type: Chapter

References (82)

1. Schmalbrock P, Chakeres DW. Clinical applications at ultrahigh fields. In: Andrä W, Nowak H, editors. Magnetism in Medicine, Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, 2007, pp. 398-415.
2. Reichenbach JR, Venkastesan R, Yablonskiy DA, Thompson MR, Lai S, Haacke EM. Theory and application of static field inhomogeneity effects in gradient-echo imaging. J. Magn. Reson. Imaging 1997;7:266-279.
3. Wiesinger F, Boesiger P, Pruessmann KP. Electrodynamics and ultimate SNR in parallel MR imaging. Magn. Reson. Med. 2004;52:376-390.
4. Pruessmann KP. Parallel imaging at high field strength: synergies and joint potential. Top. Magn. Reson. Imaging 2004;15:237-244.
5. Abduljalil AM, Schmalbrock P, NovakV, ChakeresDW. Enhanced gray and white matter contrast of phase susceptibility-weighted images in ultra-high-field magnetic resonance imaging. J. Magn. Reson. Imaging 2003;18:284-290.
6. Rauscher A, Sedlacik J, Barth M, Mentzel HJ, Reichenbach JR. Magnetic susceptibility-weighted MR phase imaging of the human brain. AJNR Am. J. Neuroradiol. 2005;26:736-742.
7. Duyn JH, van Gelderen P, Li TQ, de Zwart JA, Koretsky AP, Fukunaga M. From the cover: highfield MRI of brain cortical substructure based on signal phase. Proc. Natl. Acad. Sci. USA 2007;104:11796-11801.
8. Deistung A, Rauscher A, Sedlacik J, Stadler J, Witoszynskyj S, Reichenbach JR. Susceptibility weighted imaging at ultra high magnetic field strengths: theoretical considerations and experimental results. Magn. Reson. Med. 2008;60:1155-1168.
9. Ugurbil K, Adriany G, Andersen P, ChenW, Garwood M, Gruetter R, Henry PG, Kim SG, Lieu H, Tkac I, Vaughan T, Moortele PFVD, Yacoub E, Zhu XH. Ultrahigh field magnetic resonance imaging and spectroscopy. Magn. Reson. Imaging 2003;21:1263-1281.
10. Vaughan JT, Garwood M, Collins CM, Liu W, DelaBarre L, Adriany G, Andersen P, Merkle H, Goebel R, Smith MB, Ugurbil K. 7 T vs. 4 T: RF power, homogeneity, and signal-to-noise comparison in head images. Magn. Reson. Med. 2001;46:24-30.
11. Ladd ME. High-field-strength magnetic resonance: potential and limits. Top. Magn. Reson. Imaging 2007;18:139-152.
12. Bottomley PA, Foster TH, Argersinger RE, Pfeifer LM.Areviewof normal tissue hydrogenNMR relaxation times and relaxation mechanisms from 1-100 MHz: dependence on tissue type, NMR frequency, temperature, species, excision, and age. Med. Phys. 1984;11:425-448.
13. Zhong JH, Gore JC, Armitage IM. Relative contributions of chemical exchange and other relaxation mechanisms in protein solutions and tissues. Magn. Reson. Med. 1989;11:295-308.
14. Jezzard P, Duewell S, Balaban RS. MR relaxation times in human brain: measurement at 4 T. Radiology 1996;199:773-779.
15. Michaeli S, Garwood M, Zhu XH, DelaBarre L, Andersen P, Adriany G, Merkle H, Ugurbil K, ChenW. Proton T2 relaxation study of water, N-acetylaspartate, and creatine in human brain using Hahn and Carr-Purcell spin echoes at 4 T and 7 T. Magn. Reson. Med. 2002;47:629-633.
16. Koopmans PJ, Manniesing R, Niessen WJ,ViergeverMA,Barth M.MRvenography of the human brain using susceptibility weighted imaging at very high field strength. Magn. Reson. Mater. Phys. Biol. Med. 2008;21:149-158.
17. 2-weighted MRI of the human brain at 7.0 T. Neuroimage 2006;32:1032-1040.
18. Ge Y, Barnes S, Xu Y, Neelavalli J, Grossman R, Haacke E. Optimization of phase contrast in susceptibility weighted imaging at 7 T. In: Proceedings of the 16th Scientific Meeting, International Society for Magnetic Resonance in Medicine, Toronto, 2008 (abstract 878).
19. Robitaille PM, Abduljalil AM, Kangarlu A, Zhang X,YuY, Burgess R, Bair S, Noa P,Yang L, Zhu H, Palmer B, Jiang Z, Chakeres DM, Spigos D. Human magnetic resonance imaging at 8 T. NMR Biomed. 1998;11:263-265.
20. Abduljalil AM, Robitaille PM. Macroscopic susceptibility in ultra high field MRI. J. Comput. Assist. Tomogr. 1999;23:832-841.
21. ChristoforidisGA,BourekasEC,BaujanM,AbduljalilAM,KangarluA,SpigosDG,ChakeresDW, Robitaille PM. High resolutionMRI of the deep brain vascular anatomy at 8 Tesla: susceptibilitybased enhancement of the venous structures. J. Comput. Assist. Tomogr. 1999; 23:857-866.
22. Reichenbach JR, Barth M, Haacke EM, Klarhöfer M, KaiserWA, Moser E. High-resolution MR venography at 3.0 Tesla. J. Comput. Assist. Tomogr. 2000;24:949-957.
23. Reichenbach JR, Haacke EM. High resolution BOLD venographic imaging: a window into brain function. NMR Biomed. 2001;14:453-467.
24. Haacke EM, Xu Y, Cheng YN, Reichenbach JR. Susceptibility weighted imaging (SWI). Magn. Reson. Med. 2004;52:612-618.
25. Budde J, Pohmann R, Shajan G, Ugurbil K. Susceptibility weighted imaging of the human brain at 9.4 T. In: Proceedings of the 17th Scientific Meeting, International Society for Magnetic Resonance in Medicine, Honolulu, 2009 (abstract 43).
26. Sedlacik J, Rauscher A, Reichenbach JR. Obtaining blood oxygenation levels from MR signal behavior in the presence of single venous vessels. Magn. Reson. Med. 2007;58:1035-1044.
27. Reichenbach JR, Essig M, Haacke EM, Lee BC, Przetak C, Kaiser WA, Schad LR. Highresolutionvenography of the brain using magnetic resonance imaging. Magn. Reson. Mater. Phys. Biol. Med. 1998;6:62-69.
28. SehgalV, Delproposto Z, Haacke EM, Tong KA,Wycliffe N, Kido DK, XuY, Neelavalli J, Haddar D, Reichenbach JR. Clinical applications of neuroimaging with susceptibility-weighted imaging. J. Magn. Reson. Imaging 2005;22:439-450.
29. Lupo JM, Banerjee S, Hammond KE,KelleyDAC,XuD, Chang SM,Vigneron DB, Majumdar S, Nelson SJ. GRAPPA-based susceptibility-weighted imaging of normal volunteers and patients with brain tumor at 7 T. Magn. Reson. Imaging 2009;27:480-488.
30. Sedlacik J, Herrmann KH, Rauscher A, Reichenbach JR. SWI using different k-space undersampling mechanisms. In: Proceedings of the 13th Scientific Meeting, International Society for Magnetic Resonance in Medicine, Miami, 2005 (abstract 241).
31. Lupo J, Kelley D, Xu D, Vigneron D, Nelson S. Susceptibility-weighted imaging at 3 T and 7 T using multi-channel phased array coils and SENSE. In: Proceedings of the 14th Scientific Meeting, International Society for Magnetic Resonance in Medicine, Seattle, 2006 (abstract 2451).
32. Manniesing R, Viergever MA, Niessen WJ.
33. Frangi A, Niessen W, Vincken K, Viergever M. Multiscale vessel enhancement filtering. MICCAI & 98, LNCS 1496 1998, pp. 130-137.
34. Hernandez E, MacKay A, Rauscher A. The relationship between susceptibility weighted phase and white matter fiber orientation. In: Proceedings of the 17th Scientific Meeting, International Society for Magnetic Resonance in Medicine, Honolulu, 2009 (abstract 953).
35. He X, Yablonskiy DA. Biophysical mechanisms of phase contrast in gradient echo MRI. Proc. Natl. Acad. Sci. USA 2009;106:13558-13563.
36. Thomas BP, Welch EB, Niederhauser BD, Whetsell WO, Anderson AW, Gore JC, Avison MJ, Creasy JL. High-resolution 7 T MRI of the human hippocampus in vivo. J. Magn. Reson. Imaging 2008;28:1266-1272.
37. US Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health, Radiological Devices Branch, Division of Reproductive, Abdominal, and Radiological Devices, Office of Device Evaluation. Guidance for industry and FDA staff: Criteria for Significant Risk Investigations of Magnetic Resonance Diagnostic Devices. Updated July 14, 2003. Accessed October 1, 2009. (http://www.fda.gov/downloads/ MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm072688.pdf).
38. Chakeres DW, de Vocht F. Static magnetic field effects on human subjects related to magnetic resonance imaging systems. Prog. Biophys. Mol. Biol. 2005;87:255-265.
39. HartwigV,Giovannetti G,Vanello N, LombardiM, Landini L, Simi S. Biological effects and safety in magnetic resonance imaging: a review. Int. J. Environ. Res. Public Health 2009;6:1778-1798.
40. Brix G, Nekolla EA, Nosske D, Griebel J. Risks and safety aspects related to PET/MR examinations. Eur. J. Nucl. Med. Mol. Imaging 2009; 36 (Suppl 1): S131-S138.
41. Chakeres DW, Abduljalil AM, Novak P, Novak V. Comparison of 1.5 and 8 Tesla high-resolution magnetic resonance imaging of lacunar infarcts. J. Comput. Assist. Tomogr. 2002;26:628-632.11
42. NovakV,KangarluA,Abduljalil A, Novak P, SlivkaA,ChakeresD,RobitaillePM.Ultra high field MRI at 8 Tesla of subacute hemorrhagic stroke. J. Comput. Assist. Tomogr. 2001;25:431-435.
43. Christoforidis G, Grecula J, Newton H, Kangarlu A, Abduljalil A, Schmalbrock P, Chakeres D. Visualization of microvascularity in glioblastoma multiforme with 8-T high-spatial-resolution MR imaging. AJNR Am. J. Neuroradiol. 2002;23:1553-1556.
44. Christoforidis GA, Kangarlu A, Abduljalil AM, Schmalbrock P, Chaudhry A, Yates A, Chakeres DW. Susceptibility-based imaging of glioblastoma microvascularity at 8 T: correlation of MR imaging and postmortem pathology. AJNR Am. J. Neuroradiol. 2004;25:756-760.
45. Novak V, Chowdhary A, Abduljalil A, Novak P, Chakeres D. Venous cavernoma at 8 Tesla MRI. Magn. Reson. Imaging 2003;21:1087-1089.
46. Hammond KE, Lupo JM, Xu D, Metcalf M, Kelley DAC, Pelletier D, Chang SM, Mukherjee P, Vigneron DB, Nelson SJ. Development of a robust method for generating 7.0 T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseases. Neuroimage 2008;39:1682-1692.
47. Metcalf M, Xu D, Okuda DT, Carvajal L, Srinivasan R, Kelley DAC, Mukherjee P, Nelson SJ, Vigneron DB, Pelletier D. High-resolution phased-array MRI of the human brain at 7 Tesla: initial experience in multiple sclerosis patients. J. Neuroimaging 2010,20(2), 141-147.
48. Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, Revesz T. Cortical lesions in multiple sclerosis. Brain 1999;122(Pt 1): 17-26.
49. Ge Y, Zohrabian VM, Grossman RI. Seven-Tesla magnetic resonance imaging: new vision of microvascular abnormalities in multiple sclerosis. Arch. Neurol. 2008;65:812-816.
50. Kollia K, Maderwald S, Putzki N, Schlamann M, Theysohn JM, Kraff O, Ladd ME, Forsting M, Wanke I. First clinical study on ultra-high-field MR imaging in patients with multiple sclerosis: comparison of 1.5 T and 7 T. AJNR Am. J. Neuroradiol. 2009;30:699-702.
51. Mainero C, Benner T, Radding A, van der Kouwe A, Jensen R, Rosen BR, Kinkel RP. In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI. Neurology 2009;73:941-948.
52. Eissa A, Lebel RM, Korzan JR, Zavodni AE, Warren KG, Catz I, Emery DJ, Wilman AH. Detecting lesions in multiple sclerosis at 4.7 Tesla using phase susceptibility-weighting and T2- weighting. J. Magn. Reson. Imaging 2009;30:737-742.
53. Hammond KE, Metcalf M, Carvajal L, Okuda DT, Srinivasan R, Vigneron D, Nelson SJ, Pelletier D. Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Ann. Neurol. 2008;64:707-713.
54. Nakada T, Matsuzawa H, Igarashi H, Fujii Y, Kwee IL. In vivo visualization of senile-plaque-like pathology in Alzheimer & s disease patients by MR microscopy on a 7 T system. J. Neuroimaging 2008;18:125-129.
55. Lattanzi R, Sodickson DK, Grant AK, Zhu Y. Electrodynamic constraints on homogeneity and radiofrequency power deposition in multiple coil excitations. Magn. Reson. Med. 2009;61:315-334.
56. Wald LL, Carvajal L, Moyher SE, Nelson SJ, Grant PE, Barkovich AJ,Vigneron DB. Phased array detectors and an automated intensity-correction algorithm for high-resolutionMR imaging of the human brain. Magn. Reson. Med. 1995;34:433-439.
57. Katscher U, Börnert P, van den Brink JS. Theoretical and numerical aspects of transmit SENSE. IEEE Trans. Med. Imaging 2004;23:520-525.
58. Katscher U, Börnert P, Leussler C, van den Brink JS. Transmit SENSE. Magn. Reson. Med. 2003;49:144-150.
59. Ros C, Witoszynskyj S, Herrmann KH, Reichenbach JR. Reconstruction of phase images for GRAPPAaccelerated Magnetic Resonance Imaging. In: Sloten J,Verdonck P, Nyssen M, Haueisen J,editors. 4th European Conference of the International Federation for Medical and Biological Engineering ECIFMBE 2008, IFMBE Proceedings, Vol. 22 Springer-Verlag GmbH, 2009, pp. 803-806.
60. Pruessmann KP, Weiger M, Scheidegger MB, Boesiger P. SENSE: sensitivity encoding for fast MRI. Magn. Reson. Med. 1999;42:952-962.
61. Zhang Y, Li S, Shen J. Automatic high-order shimming using parallel columns mapping (PACMAP). Magn. Reson. Med. 2009;62:1073-1079.
62. Poole M, Bowtell R.Volume parcellation for improved dynamic shimming. Magn. Reson. Mater. Phys. Biol. Med. 2008;21:31-40.
63. Juchem C, Muller-Bierl B, Schick F, Logothetis NK, Pfeuffer J. Combined passive and active shimming for in vivoMRspectroscopy at high magnetic fields. J.Magn. Reson. 2006;183:278-289.
64. Bottomley PA, Andrew ER. RF magnetic field penetration, phase shift and power dissipation in biological tissue: implications for NMR imaging. Phys. Med. Biol. 1978;23:630-643.
65. Keltner JR, Carlson JW, Roos MS, Wong ST, Wong TL, Budinger TF. Electromagnetic fields of surface coil in vivo NMR at high frequencies. Magn. Reson. Med. 1991;22:467-480.
66. Witoszynskyj S, Rauscher A, Reichenbach JR, Barth M. Phase unwrapping of MR images using Phi UN-a fast and robust region growing algorithm. Med. Image Anal. 2009;13:257-268.
67. Neelavalli J, Cheng YCN, Jiang J, Haacke EM. Removing background phase variations in susceptibility-weighted imaging using a fast, forward-field calculation. J. Magn. Reson. Imaging 2009;29:937-948.
68. Stanisz GJ, Odrobina EE, Pun J, Escaravage M, Graham SJ, Bronskill MJ, Henkelman RM. T1, T2 relaxation and magnetization transfer in tissue at 3 T. Magn. Reson. Med. 2005;54:507-512.
69. Silvennoinen MJ, Clingman CS, Golay X, Kauppinen RA, van Zijl PC. Comparison of the dependence of blood R2 and R2* on oxygen saturation at 1.5 and 4.7 Tesla. Magn. Reson. Med. 2003;49:47-60.
70. 2measurements in human brain at 1.5, 3 and 7 T. Magn. Reson. Imaging 2007;25:748-753.
71. Zhao JM, Clingman CS,Närväinen MJ, Kauppinen RA, van Zijl PC. Oxygenation and hematocrit dependence of transverse relaxation rates of blood at 3 T. Magn. Reson. Med. 2007;58:592-597.
72. Dobre MC, Ugurbil K, Marjanska M. Determination of blood longitudinal relaxation time (T1) at high magnetic field strengths. Magn. Reson. Imaging 2007;25:733-735.
73. Pfeuffer J, Merkle H, Beyerlein M, Steudel T, Logothetis NK. Anatomical and functional MR imaging in the macaque monkey using a vertical large-bore 7 Tesla setup. Magn. Reson. Imaging 2004;22:1343-1359.
74. Bonny J, Durif F, Bazin JE, Touraille E, Yelnik J, Renou JP. Contrast optimization of Macaca mulatta basal ganglia in magnetic resonance images at 4.7 Tesla. J. Neurosci. Methods 2001;107:25-30.
75. 2O relaxation in vivo. Magn. Reson. Med. 2007;57:308-318.
76. Yacoub E, Shmuel A, Pfeuffer J,VanDe Moortele PF, Adriany G, Andersen P,Vaughan JT, Merkle H, Ugurbil K, Hu X. Imaging brain function in humans at 7 Tesla. Magn. Reson. Med. 2001;45:588-594.
77. Yacoub E, Duong TQ, Van De Moortele PF, Lindquist M, Adriany G, Kim SG, Ugurbil K, Hu X. Spin-echo fMRI in humans using high spatial resolutions and high magnetic fields. Magn. Reson. Med. 2003;49:655-664.
78. Bilgen M, Al-Hafez B, Malone TM, Smirnova IV. Ex vivo magnetic resonance imaging of rat spinal cord at 9.4 T. Magn. Reson. Imaging 2005;23:601-605.
79. Lee SP, Silva AC, Ugurbil K, Kim SG. Diffusion-weighted spin-echo fMRI at 9.4 T: microvascular/ tissue contribution to BOLD signal changes. Magn. Reson. Med. 1999;42:919-928.
80. Zhao F,Wang P, Kim SG. Cortical depth-dependent gradient-echo and spin-echo BOLD fMRI at 9.4 T. Magn. Reson. Med. 2004;51:518-524.
81. Nakada T, Matsuzawa H, Kwee IL. High-resolution imaging with high and ultra high-field magnetic resonance imaging systems. Neuroreport 2008;19:7-13.
82. Yang Q, Liu J, Barnes SR,Wu Z, Li K, Neelavalli J, Hu J, Haacke EM. Imaging the vessel wall in major peripheral arteries using susceptibility-weighted imaging. J. Magn. Reson. Imaging 2009;30:357-365.